Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy

Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy

US Patent 11795229 · Granted Oct 24, 2023

Estimated economic value: $173,303,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using a bispecific antigen-binding construct targeting HER2 for the t2025
Methods of reducing immunogenicity against factor VIII in individuals undergoing2025
Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer2022
Methods of reducing immunogenicity against factor VIII in individuals undergoing2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2021
Methods of reducing immunogenicity against factor VIII in individuals undergoing2019
Suppression of immune response to factor VIII in hemophilia A patients2014